• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Weekly Roundup: July 20-24

Article

ICYMI, some of the content featured this week includes a new episode of The Cutaneous Connection, how to eat for healthy skin, botulinum toxin as a potential treatment for scars, fat grafting, plus more.

In case you missed it, this week we released a new episode of our podcast, The Cutaneous Connection, which takes a look at a recent International Society of Dermatology survey asking about climate change and its effect on skin diseases. Also, we featured articles about fat grafting, botulinum toxin as a potential treatment for scars, U.S. Food and Drug Administration approval of a new plaque psoriasis topical, how to eat for healthy skin, plus more.

The Cutaneous Connection: Episode 3- Climate Change and Skin Diseases

This episode discusses a recent survey conducted by the International Society of Dermatology’s Climate Change Committee involving climate change and its effect on skin diseases throughout the world with one of its committee members, Sarah Coates, M.D.

Develop a list of potential buyers, and perform your own initial due diligence

This month, Todd Petersen, CEO of VitalSkin Dermatology, focuses on how to identify potential buyers and perform your own initial due diligence on them before putting your practice up for sale.

The Mainstream Patient: July 20

This week’s edition of The Mainstream Patient features stories about the difference between physical and chemical sunscreen, everything you need to know about exfoliants, a complete guide to laser hair removal, plus more.

Is Covid-19 a defense to a battery charge?

Dr. Joe acquired a new laser prior to the pandemic. Three patients are scheduled for treatment during which he had told them a laser expert would be present. The laser expert deferred due to COVID-19. After carrying out the procedures alone, one patient sues for battery, though there were no adverse events. Is this battery? Can Dr. Joe use COVID-19 challenges as a defense?

Skin microbiome altered in some rosacea subtypes

A recent study aimed to elucidate the association between variations in the skin’s microbiome and the development of rosacea symptoms.

How does botulinum toxin treat scars?

Hema Sundaram, M.A., M.D., FAAD, breaks down how botulinum toxin can be used to treat scars, a topic she discussed during her presentation at the AAD Virtual Meeting Experience (VMX) on June 12.

How to eat for healthy skin

Special skin mineral supplementation is not necessary as long as patients make educated dietary choices.

The power of fat grafting

In this video, Hema Sundaram, M.A., M.D., FAAD, shares pearls on fat grafting from her presentation at the AAD Virtual Meeting Experience (VMX) in June.

DMK introduces Summer Body package

DMK Skin Care launches new products at their U.S. DMK clinics to help combat the effects of summer on the skin.

Can botulinum toxin benefit rosacea patients?

Botulinum toxin may help address erythema and flushing in patients with refractory rosacea, according to data presented by Hema Sundaram, M.A., M.D., FAAD, at the AAD Virtual Meeting Experience (VMX) on June 12.

Therapeutic, management considerations with biologics

Studies offer further insight into risks associated with biologic therapy. One study suggests it’s not necessary to stop biologic therapy preoperatively to limit post-operative infections. Another systematic review does not rule out melanoma risk.

The promise of laser-assisted drug delivery

In this video, Hema Sundaram, M.A., M.D., FAAD, highlights important safety considerations to keep in mind regarding laser-assisted drug delivery.

FDA approves plaque psoriasis topical

The U.S. Food and Drug Administration has approved Wynzora Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064%, MC2 Therapeutics) for adult with plaque psoriasis. Wynzora is equipped with the MC2 Therapeutics’ patented PAD Technology and is currently under review in the EU.

Natural retinol alternative powers skincare renewal products

Bakuchiol offers patients the skin renewal benefits of retinol without the irritation, redness, peeling and sun-sensitivity.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.